The BIOCOM 4th AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
In view of the continuing uncertain situation and travel restrictions due to the COVID-19 pandemic, the 4th AMR Conference will take place as a digital event during the week of 24–28 August 2020.
Find out more about this year’s conference here
Sessions with speakers from GARDP include:
Day 1: Monday August 25
Opening Session | Infectious diseases in the global spotlight: Why COVID-19 has an impact on AMR
Manica Balasegaram – Executive Director, GARDP
Christian Drosten – Director of Institute of Virology, Charité (tbc)
Jordi Vila – Head of Service, Biomedical Diagnostic Center, Microbiology, Hospital Clinic Barcelona (tbc)
Day 2: Tuesday August 25
Business models | The AMR company of the future – Which route to success
Marc Gitzinger – CEO, BioVersys AG
Cherif Bousselham – Head of EMEA (Europe, Middle East and Africa), Accelerate Diagnostics Inc.
Jean-Pierre Paccaud – Director of Business Development and Corporate Strategy, GARDP
Ken Bradley – Global Head, Infectious Disease Discovery, Roche
Day 3: Wednesday August 26
Clinical trials | Why global networks are crucial to speed up late stage clinical development
Seamus O’Brien, R&D Director, GARDP
Tim Jinks, Head of Antibiotic Resistance Infections Program, Wellcome Trust
Florence Séjourne, CEO, DaVolterra
Kamini Walia, Head of AMR, ICMR, Government of India